NP&PP department – Psychopharmacology In Maastricht

2C-B is a hallucinogenic phenethylamine derived from mescaline. First made by the grand wizard of psychedelic biochemistry Sasha Shulgin in 1974, 2C-B became his favourite of the "magical-half dozen" of substituted phenethylamines. Published in his seminal book PIHKAL, 2C-B promptly reached the wider world of recreational users. However, despite being the most popular 2C-X compound… Continue reading How does 2C-B compare to psilocybin and placebo regarding subjective effects, mood and cognition?

microdosing, NP&PP department, NPS, psychedelics

Kim P.C. Kuypers on DOCS

February 1, 2023 psychopharmacologymaastricht

Our very own Prof. Kim Kuypers talks about the psychedelic research carried out at our department for DOCS! Click on the link to listen to the Trip Generation episode (in Dutch).

Addiction, Event, NP&PP department

Addiction – The realm of myth

November 24, 2022November 24, 2022 psychopharmacologymaastricht

Peter van Ruitenbeek, assistant professor at our Department, gave a talk about what addiction actually entails beyond the conventional narrative focused on the acute increase in dopamine levels that substances of abuse cause. Here is a summary of his interesting presentation hosted by the 2022 edition of the Pleasure, Art and Science Festival 2022. In… Continue reading Addiction – The realm of myth

Event, NP&PP department, Psychedelic-Assisted Psychotherapy, psychedelics

Save the date – What do we mean by Psychedelic-Assisted Psychotherapy?

September 17, 2022September 17, 2022 psychopharmacologymaastricht

On September 28 uniMIND Central Session will host Mauro Cavarra for an open discussion on our recently published paper reviewing the different models of psychedelic-assisted psychotherapy used in clinical trials. The session will start at 7pm (CEST) and anyone is welcome to join via the MIND Community Platform.

microdosing, NP&PP department, pain, psychedelics, survey

Analgesic potential of psychedelics in chronic pain sufferers: a population survey

September 14, 2022 psychopharmacologymaastricht

Do psychedelics work for chronic pain? We asked the patients themselves! In our recent article we present the results of a survey study addressed to chronic pain sufferers who are using psychedelics (both in full doses and in microdoses) to seek relief. Our results support the hypothesis that both dosing regimens hold promise for chronic… Continue reading Analgesic potential of psychedelics in chronic pain sufferers: a population survey